TECP

Trails Edge Capital Partners Portfolio holdings

AUM $405M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$405M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$33.9M
2
+$33M
3
+$31.8M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$25.1M
5
NRIX icon
Nurix Therapeutics
NRIX
+$25M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
1
Acadia Pharmaceuticals
ACAD
$4.22B
$37.9M 9.37%
+1,419,406
DFTX
2
Definium Therapeutics
DFTX
$1.74B
$34.4M 8.5%
+2,568,110
PCVX icon
3
Vaxcyte
PCVX
$9.05B
$34M 8.41%
+737,470
NRIX icon
4
Nurix Therapeutics
NRIX
$1.62B
$33.1M 8.17%
+1,743,220
LBRX
5
LB Pharmaceuticals
LBRX
$636M
$31.1M 7.68%
+1,395,608
XENE icon
6
Xenon Pharmaceuticals
XENE
$3.44B
$26.8M 6.61%
+597,092
IMCR icon
7
Immunocore
IMCR
$1.63B
$23.7M 5.85%
+682,597
RCUS icon
8
Arcus Biosciences
RCUS
$2.51B
$21.8M 5.4%
+916,313
TYRA icon
9
Tyra Biosciences
TYRA
$1.84B
$18.4M 4.55%
+700,000
NGNE icon
10
Neurogene
NGNE
$311M
$16.2M 4%
+785,000
FOLD icon
11
Amicus Therapeutics
FOLD
$4.5B
$14.9M 3.67%
+1,043,313
APGE icon
12
Apogee Therapeutics
APGE
$4.84B
$14.5M 3.58%
+192,000
IKT icon
13
Inhibikase Therapeutics
IKT
$260M
$12.7M 3.13%
+6,178,124
IVA
14
Inventiva
IVA
$1.41B
$12.4M 3.05%
+2,657,997
CAMP icon
15
CAMP4 Therapeutics
CAMP
$231M
$12.2M 3%
+1,983,986
TERN icon
16
Terns Pharmaceuticals
TERN
$4.5B
$12.1M 2.99%
+300,000
XFOR icon
17
X4 Pharmaceuticals
XFOR
$301M
$10.3M 2.54%
+2,571,478
MBX
18
MBX Biosciences
MBX
$1.6B
$9.94M 2.46%
+315,158
VTVT icon
19
vTv Therapeutics
VTVT
$152M
$9.24M 2.28%
+231,000
CMPX icon
20
Compass Therapeutics
CMPX
$1.05B
$7.6M 1.88%
+1,415,273
IMVT icon
21
Immunovant
IMVT
$5.54B
$6.1M 1.51%
+240,165
ELVN icon
22
Enliven Therapeutics
ELVN
$1.74B
$3.07M 0.76%
+199,306
MIRM icon
23
Mirum Pharmaceuticals
MIRM
$6.5B
$2.52M 0.62%
+31,862